American Bio Medica Corp (ABMC) SEC Filing 10-Q Quarterly report for the period ending Friday, June 30, 2017

American Bio Medica Corp

CIK: 896747 Ticker: ABMC
Document And Entity Information - shares
6 Months Ended
Jun. 30, 2017
Aug. 14, 2017
Document Information [Line Items]  
Document Type10-Q 
Amendment Flagfalse 
Document Period End DateJun. 30, 2017 
Document Fiscal Year Focus2017 
Document Fiscal Period FocusQ2 
Entity Central Index Key0000896747 
Current Fiscal Year End Date--12-31 
Entity Filer CategorySmaller Reporting Company 
Trading SymbolABMC 
Entity Common Stock, Shares Outstanding 29,297,333

View differences made from one quarter to another to evaluate American Bio Medica Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by American Bio Medica Corp.


Assess how American Bio Medica Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

American Bio Medica Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2017 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

American Bio Medica Corp provided additional information to their SEC Filing as exhibits

Ticker: ABMC
CIK: 896747
Form Type: 10-Q Quarterly Report
Accession Number: 0001144204-17-042918
Submitted to the SEC: Mon Aug 14 2017 12:38:20 PM EST
Accepted by the SEC: Mon Aug 14 2017
Period: Friday, June 30, 2017
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: